Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae

Proceedings of the National Academy of Sciences of the United States of America

Volumn 115, Issue 12, 2018, Pages 3102-3107

  Obolski, Uri ^a   Lourenço, José ^a   Thompson, Craig ^a   Thompson, Robin ^a   Gori, Andrea ^b   Gupta, Sunetra ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antibiotic resistance; Ecological competition; Epidemiology; Mathematical model; Streptococcus pneumoniae

Indexed keywords

CEFTRIAXONE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT; PNEUMOCOCCUS VACCINE; VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CONTROLLED STUDY; DRUG EFFECT; GENE FREQUENCY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION; BIOLOGICAL MODEL; CLASSIFICATION; COMPUTER SIMULATION; HUMAN; IMMUNOLOGY; PNEUMOCOCCAL INFECTION;

ANTI-BACTERIAL AGENTS; COMPUTER SIMULATION; DRUG RESISTANCE, BACTERIAL; HUMANS; MODELS, BIOLOGICAL; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROGROUP; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 85044255376     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1718712115     Document Type: Article

References (73)

1. World Health Organization (2012) Measuring Impact of Streptococcus pneumoniae and Haemophilus influenzae Type b Conjugate Vaccination (World Health Org, Geneva).
2. Parks T, Barrett L, Jones N (2015) Invasive streptococcal disease: A review for clinicians. Br Med Bull 115:77-89.
3. Ventola CL (2015) The antibiotic resistance crisis: Part 1: Causes and threats. P&T 40: 277-283.
4. Reynolds CA, Finkelstein JA, Ray GT, Moore MR, Huang SS (2014) Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: A cost analysis. Antimicrob Resist Infect Control 3:16.
5. Einarsson S, Kristjansson M, Kristinsson KG, Kjartansson G, Jonsson S (1998) Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: A case-control study. Scand J Infect Dis 30:253-256.
6. Schrag SJ, et al. (2001) Resistant Pneumococcal Infections: The Burden of Disease and Challenges in Monitoring and Controlling Antimicrobial Resistance (World Health Org, Geneva).
7. Kim L, McGee L, Tomczyk S, Beall B (2016) Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre-and post-conjugate vaccine eras: A United States perspective. Clin Microbiol Rev 29:525-552.
8. Metlay JP, et al. (2000) Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 30:520-528.
9. Feikin DR, et al. (2000) Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 90:223-229.
10. Tleyjeh IM, Tlaygeh HM, Hejal R, Montori VM, Baddour LM (2006) The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: A systematic review and meta-analysis. Clin Infect Dis 42:788-797.
11. Brown J, Hammerschmidt S, Orihuela C (2015) Streptococcus Pneumoniae: Molecular Mechanisms of Host-Pathogen Interactions (Academic, New York).
12. Hanage WP (2007) Serotype replacement in invasive pneumococcal disease: Where do we go from here? J Infect Dis 196:1282-1284.
13. Weinberger DM, Malley R, Lipsitch M (2011) Serotype replacement in disease after pneumococcal vaccination. Lancet 378:1962-1973.
14. Lipsitch M (1999) Bacterial vaccines and serotype replacement: Lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis 5:336-345.
15. Beall BW, et al. (2011) Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis 203:1360-1368.
16. Croucher NJ, et al. (2013) Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet 45:656-663.
17. Gupta S, Ferguson NM, Anderson RM (1997) Vaccination and the population structure of antigenically diverse pathogens that exchange genetic material. Proc Biol Sci 264: 1435-1443.
18. Watkins ER, et al. (2015) Vaccination drives changes in metabolic and virulence profiles of Streptococcus pneumoniae. PLoS Pathog 11:e1005034.
19. Dagan R, Muallem M, Melamed R, Leroy O, Yagupsky P (1997) Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J 16:1060-1064.
20. Dagan R, Givon-Lavi N, Zamir O, Fraser D (2003) Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J 22:532-540.
21. Mbelle N, et al. (1999) Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 180:1171-1176.
22. Mishra RP, Oviedo-Orta E, Prachi P, Rappuoli R, Bagnoli F (2012) Vaccines and antibiotic resistance. Curr Opin Microbiol 15:596-602.
23. Chiba N, et al.; Invasive Pneumococcal Diseases Surveillance Study Group (2013) Rapid decrease of 7-valent conjugate vaccine coverage for invasive pneumococcal diseases in pediatric patients in Japan. Microb Drug Resist 19:308-315.
24. Moore MR, et al. (2008) Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 197:1016-1027.
25. Hanage WP, et al. (2007) Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis 195:347-352.
26. Kyaw MH, et al.; Active Bacterial Core Surveillance of the Emerging Infections Program Network (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354:1455-1463.
27. Park SY, et al. (2008) Impact of conjugate vaccine on transmission of antimicrobialresistant Streptococcus pneumoniae among Alaskan children. Pediatr Infect Dis J 27: 335-340.
28. Huang SS, et al. (2005) Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116:e408-e413.
29. Pillai DR, et al. (2009) Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics 10:642.
30. Gherardi G, et al. (2012) Serotype and clonal evolution of penicillin-nonsusceptible invasive Streptococcus pneumoniae in the 7-valent pneumococcal conjugate vaccine era in Italy. Antimicrob Agents Chemother 56:4965-4968.
31. Dagan R, Klugman KP (2008) Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 8:785-795.
32. Farrell DJ, Klugman KP, Pichichero M (2007) Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J 26:123-128.
33. Greene SK, et al. (2012) Trends in antibiotic use in Massachusetts children, 2000-2009. Pediatrics 130:15-22.
34. Grijalva CG, Nuorti JP, Griffin MR (2009) Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 302:758-766.
35. Gladstone RA, et al. (2015) Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction. Vaccine 33:2015-2021.
36. Diekmann O, Heesterbeek JAP (2000) Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation (Wiley, New York), Vol 5.
37. Maher MC, et al. (2012) The fitness cost of antibiotic resistance in Streptococcus pneumoniae: Insight from the field. PLoS One 7:e29407.
38. Rozen DE, McGee L, Levin BR, Klugman KP (2007) Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 51:412-416.
39. Trzcinski K, Thompson CM, Gilbey AM, Dowson CG, Lipsitch M (2006) Incremental increase in fitness cost with increased β-lactam resistance in pneumococci evaluated by competition in an infant rat nasal colonization model. J Infect Dis 193:1296-1303.
40. Albarracín Orio AG, Piñas GE, Cortes PR, Cian MB, Echenique J (2011) Compensatory evolution of pbp mutations restores the fitness cost imposed by β-lactam resistance in Streptococcus pneumoniae. PLoS Pathog 7:e1002000.
41. Andersson DI, Hughes D (2010) Antibiotic resistance and its cost: Is it possible to reverse resistance? Nat Rev Microbiol 8:260-271.
42. Andersson DI, Levin BR (1999) The biological cost of antibiotic resistance. Curr Opin Microbiol 2:489-493.
43. Lenski RE (1998) Bacterial evolution and the cost of antibiotic resistance. Int Microbiol 1:265-270.
44. Lehtinen S, et al. (2017) Evolution of antibiotic resistance is linked to any genetic mechanism affecting bacterial duration of carriage. Proc Natl Acad Sci USA 114: 1075-1080.
45. Gupta S, Swinton J, Anderson RM (1994) Theoretical studies of the effects of heterogeneity in the parasite population on the transmission dynamics of malaria. Proc Biol Sci 256:231-238.
46. Lipsitch M, Bergstrom CT, Levin BR (2000) The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions. Proc Natl Acad Sci USA 97:1938-1943.
47. Colijn C, et al. (2009) What is the mechanism for persistent coexistence of drugsusceptible and drug-resistant strains of Streptococcus pneumoniae? J R Soc Interface 7: 905-919.
48. Lipsitch M, et al. (2012) Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model. Epidemiology 23:510-519.
49. Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M (2014) A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis 14:13.
50. Flasche S, et al. (2011) Effect of pneumococcal conjugate vaccination on serotypespecific carriage and invasive disease in England: A cross-sectional study. PLoS Med 8: e1001017.
51. Obaro S, Adegbola R (2002) The pneumococcus: Carriage, disease and conjugate vaccines. J Med Microbiol 51:98-104.
52. Opatowski L, Guillemot D, Boëlle PY, Temime L (2011) Contribution of mathematical modeling to the fight against bacterial antibiotic resistance. Curr Opin Infect Dis 24: 279-287.
53. Caudill L, Wares JR (2016) The role of mathematical modeling in designing and evaluating antimicrobial stewardship programs. Curr Treat Options Infect Dis 8: 124-138.
54. Obolski U, Stein GY, Hadany L (2015) Antibiotic restriction might facilitate the emergence of multi-drug resistance. PLoS Comput Biol 11:e1004340.
55. Obolski U, Hadany L (2012) Implications of stress-induced genetic variation for minimizing multidrug resistance in bacteria. BMC Med 10:89.
56. Day T, Gandon S (2012) The evolutionary epidemiology of multilocus drug resistance. Evolution 66:1582-1597.
57. Bonhoeffer S, Lipsitch M, Levin BR (1997) Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA 94:12106-12111.
58. Mitchell PK, Lipsitch M, Hanage WP (2015) Carriage burden, multiple colonization and antibiotic pressure promote emergence of resistant vaccine escape pneumococci. Philos Trans R Soc Lond B Biol Sci 370:20140342.
59. Temime L, Guillemot D, Boëlle PY (2004) Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrob Agents Chemother 48:2206-2213.
60. Papadimitriou-Olivgeris M, et al. (2015) Co-colonization by multidrug-resistant bacteria in two Greek intensive care units. Eur J Clin Microbiol Infect Dis 34:1947-1955.
61. Hayakawa K, et al. (2013) Independent risk factors for the co-colonization of vancomycinresistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation. Eur J Clin Microbiol Infect Dis 32:815-820.
62. Cohen NA, Maharshak N (2017) Novel indications for fecal microbial transplantation: Update and review of the literature. Dig Dis Sci 62:1131-1145.
63. Cobey S, Lipsitch M (2013) Pathogen diversity and hidden regimes of apparent competition. Am Nat 181:12-24.
64. Lourenço J, et al. (2017) Lineage structure of Streptococcus pneumoniae may be driven by immune selection on the groEL heat-shock protein. Sci Rep 7:9023.
65. Pál C, Papp B, Lázár V (2015) Collateral sensitivity of antibiotic-resistant microbes. Trends Microbiol 23:401-407.
66. Imamovic L, Sommer MO (2013) Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med 5:204ra132.
67. Obolski U, Dellus-Gur E, Stein GY, Hadany L (2016) Antibiotic cross-resistance in the lab and resistance co-occurrence in the clinic: Discrepancies and implications in E.coli. Infect Genet Evol 40:155-161.
68. O'Neill J (2016) Infection Prevention, Control and Surveillence: Limiting the Development and Spread of Drug Resistance (Rev Antimicrobial Resistance, London), pp 1-32.
69. Fish DN, Piscitelli SC, Danziger LH (1995) Development of resistance during antimicrobial therapy: A review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy 15:279-291.
70. Gillespie DT (1976) A general method for numerically simulating the stochastic time evolution of coupled chemical reactions. J Comput Phys 22:403-434.
71. Jolley KA, Maiden MC (2010) BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11:595.
72. Corander J, Marttinen P (2006) Bayesian identification of admixture events using multilocus molecular markers. Mol Ecol 15:2833-2843.
73. Corander J, Marttinen P, Sirén J, Tang J (2008) Enhanced Bayesian modelling in BAPS software for learning genetic structures of populations. BMC Bioinformatics 9:539.